← Open Payments lookup

BRITTANY MATNEY: Open Payments

NPI 1013492966 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,940 in 292 payments from 19 companies in 2025. Trend: 2023 $4,041 · 2024 $3,941 · 2025 $4,940

Food & beverage: $4,940
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)33$705
ABBVIE INC.36$580
Vanda Pharmaceuticals Inc.22$485
E.R. Squibb & Sons, L.L.C.21$468
HARMONY BIOSCIENCES LLC23$435
Alkermes, Inc.38$380
Otsuka America Pharmaceutical, Inc.21$380
Axsome Therapeutics, Inc.21$306
Neurocrine BioSciences, Inc.18$271
Teva Pharmaceuticals USA, Inc.19$267

Products named: CAPLYTA, VRAYLAR, COBENFY, WAKIX, REXULTI, ARISTADA, INGREZZA, HETLIOZ.

Industry payments across NE — which companies pay providers there.